CoreLife Healthcare

What CoreLife Healthcare does

CoreLife Healthcare is a Millersville, Maryland-headquartered (operating primarily across the Southeast US) obesity care platform founded in 2012 that delivers multidisciplinary treatment for individuals with obesity, with a particular focus on patients receiving GLP-1 pharmacotherapy. The company's core product, the CoreLife Obesity Care Program, bundles four clinical service lines — GLP-1 medication management, nutrition counseling, physical activity support, and behavioral health services — into a single integrated care protocol designed to produce sustained clinical and patient-centered outcomes rather than medication-only results. Operationally, CoreLife delivers care through a network of 11 CoreLife Novant Health co-branded clinics across North Carolina, leveraging its partnership with the Novant Health regional health system as the primary patient referral and distribution channel.

The company's business model is a clinic-based clinical services model: revenue is generated from patient encounters across the integrated multidisciplinary care offering, supplemented by GLP-1 prescription margin where applicable. End-customers are individual patients seeking comprehensive obesity treatment; the B2B layer consists of strategic partners, most notably Novant Health (health system channel) and Omnia Health Solutions (research partner). In February 2026, CoreLife entered a research collaboration with Omnia Health Solutions to support the BEACON Study, an IRB-approved real-world outcomes study that will evaluate long-term clinical and patient-centered outcomes of GLP-1 therapy within CoreLife's multidisciplinary model compared to broader study populations, with findings intended for publication and presentation.

Leadership is concentrated with the Kostkowski family: Sean Kostkowski serves as President and Founder, Raymond Kostkowski as Chairman, and Ryan Ebersole as COO. The company operates as a private for-profit entity with 251–500 employees and no public funding history disclosed in the available data. No AI/ML capabilities, technology stack details, or proprietary software platform are described in the available sources, and the company's differentiation rests on clinical care model design and health system channel integration rather than technology infrastructure.

Name

CoreLife Healthcare

Website

https://corelifemd.com

Company type

Private

Founded year

2012

Operating status

Operating

Headcount range

101–250 employees

Short description

CoreLife Healthcare operates a multidisciplinary obesity care platform that integrates GLP-1 medication therapy with nutrition, physical activity, and behavioral support services, serving patients across 11 co-branded clinics in North Carolina through a partnership with Novant Health.

Ownership category

akta.pro rank

Product category

Obesity Care Services

NAICS

Diet and Weight Reducing Centers (812191)

SIC

Services-Offices & Clinics Of Doctors Of Medicine (8011), Services-Health Services (8000)

akta.pro primary industry

Obesity Medicine & Weight Management (HLAKADAL)

akta.pro secondary industries

Medical Nutrition Therapy (Registered Dietitian) (HSADAFAE), Chronic Condition Lifestyle Coaching (Non-Clinical) (HSADAGAH)

Keywords

• Obesity treatment services
• Weight management care
• GLP-1 therapy programs
• Multidisciplinary healthcare
• Behavioral nutrition support

Headquarters

HQ city

Millersville

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Supply Chain, Marketing or Sales, Technology or R&D

Core offering

CoreLife Healthcare delivers a multidisciplinary obesity treatment program that combines GLP-1 medication therapy with nutrition counseling, physical activity support, and behavioral health services. The program is offered through physical clinic locations, including 11 CoreLife Novant Health sites in North Carolina, and is being evaluated for long-term clinical and patient-centered outcomes through the BEACON Study research partnership.

Product overview

CoreLife Healthcare operates a multidisciplinary obesity care model that provides comprehensive treatment for individuals with obesity, primarily through GLP-1 based medication therapy. The company offers an integrated approach combining medication, nutrition counseling, physical activity support, and behavioral health services. CoreLife Healthcare runs 11 CoreLife Novant Health clinics in North Carolina that participate in the BEACON Study research initiative.

Differentiator

Problem solved

Functional benefit

Products and services

• CoreLife Obesity Care Program

Named customers1 record

Segments1 record

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

Two partnerships are on record, tiered core.

• Omnia Health SolutionscoreStrategic or Co-development Partner · 11 February 2026Research collaboration supporting the BEACON Study, an IRB-approved real-world outcomes study evaluating long-term clinical and patient-centered outcomes among individuals treated with GLP-1 therapies for obesity. Omnia will conduct cohort sub-analysis to evaluate outcomes within CoreLife's multidisciplinary care model compared to the broader study population. Findings intended to be shared through abstracts, presentations, and publications.
• Novant HealthcoreStrategic or Co-development Partner11 CoreLife Novant Health clinics in North Carolina serve as referral sites for the BEACON Study, referring eligible patients into the research program for evaluation of GLP-1 therapy outcomes within CoreLife's multidisciplinary obesity care model.

Scale indicators1 record

Recent moves4 records

Expansion highlights4 records

Direct peers

• Form Health: Form Health provides physician-led, multidisciplinary obesity care combining GLP-1 medication with nutrition and behavioral support via telehealth and in-person. Closest direct competitor to CoreLife's integrated care model.
• Calibrate: Calibrate delivers a metabolic health program that pairs GLP-1 pharmacotherapy with one-on-one coaching in nutrition, sleep, exercise, and emotional health. Directly comparable to CoreLife's wraparound care approach.
• Mochi Health: Mochi Health is an obesity medicine practice offering GLP-1 prescriptions with physician oversight, nutrition support, and ongoing care coordination—mirroring CoreLife's multidisciplinary prescription-plus-support model.

Broad incumbents

• WeightWatchers (WW): WW is an established incumbent in weight management that has pivoted into the GLP-1 era via its WeightWatchers Clinic (telehealth prescribing) and acquisition of Sequence. Competes in the same patient population as CoreLife but with a much broader, predominantly behavioral legacy brand.
• Noom: Noom is a large-scale digital health platform offering behavior-change weight management programs with coaching and, more recently, GLP-1 support. Comparable as a comprehensive weight management offering targeting similar consumer segments.
• Eli Lilly (Lilly Direct): Eli Lilly, manufacturer of Zepbound (tirzepatide), has launched direct-to-patient dispensing channels that bypass traditional care delivery. As the GLP-1 originator, Lilly shapes both supply and competitive dynamics CoreLife navigates.

Emerging players

• Hims & Hers Health: Hims & Hers has rapidly expanded into telehealth weight loss offering GLP-1 access alongside its broader men's and women's health platform. A growing competitor targeting the same GLP-1-seeking consumer demographic as CoreLife.
• Ro: Ro operates a direct-to-patient telehealth platform that includes a weight management program with physician consultations and GLP-1 prescriptions, overlapping CoreLife's target use case through a digital-first delivery model.
• Found (formerly Found Health): Found offers telehealth-based obesity treatment combining prescription medication (including GLP-1s where appropriate) with personalized behavior coaching. A digitally delivered analogue to CoreLife's clinic-based multidisciplinary approach.
• Henry Meds: Henry Meds is a telehealth provider offering GLP-1 weight loss treatment with physician oversight and ongoing support, competing for the same patient population CoreLife serves but primarily through a virtual model.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights5 records

Customer concentration

• Xx.com/corelifemd
• Facebookfacebook.com/corelife

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about CoreLife Healthcare